Hickey, K.; Gill, S.; Breen, Z.; Harding, K.; Yaremko, H.; Mathieson, A.; Power, P.; Pace, D.; Neveu, J.
Feasibility of a Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Program for Gastrointestinal and Gynecological Cancer Care in Newfoundland and Labrador. Onco 2025, 5, 16.
https://doi.org/10.3390/onco5020016
AMA Style
Hickey K, Gill S, Breen Z, Harding K, Yaremko H, Mathieson A, Power P, Pace D, Neveu J.
Feasibility of a Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Program for Gastrointestinal and Gynecological Cancer Care in Newfoundland and Labrador. Onco. 2025; 5(2):16.
https://doi.org/10.3390/onco5020016
Chicago/Turabian Style
Hickey, Kala, Stephanie Gill, Zoë Breen, Kaitlyn Harding, Hannah Yaremko, Alex Mathieson, Patti Power, David Pace, and Joannie Neveu.
2025. "Feasibility of a Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Program for Gastrointestinal and Gynecological Cancer Care in Newfoundland and Labrador" Onco 5, no. 2: 16.
https://doi.org/10.3390/onco5020016
APA Style
Hickey, K., Gill, S., Breen, Z., Harding, K., Yaremko, H., Mathieson, A., Power, P., Pace, D., & Neveu, J.
(2025). Feasibility of a Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Program for Gastrointestinal and Gynecological Cancer Care in Newfoundland and Labrador. Onco, 5(2), 16.
https://doi.org/10.3390/onco5020016
